A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Eligible for screening study DCP 001
BR007 is closed to accrual, effective April 8, 2026 at 5PM ET.
BR007, HRQOL Sub-study, is closed to accrual, effective April 24, 2023.
